JPS5826327B2 - Hokosokyuuruino Goseihou - Google Patents
Hokosokyuuruino GoseihouInfo
- Publication number
- JPS5826327B2 JPS5826327B2 JP49133573A JP13357374A JPS5826327B2 JP S5826327 B2 JPS5826327 B2 JP S5826327B2 JP 49133573 A JP49133573 A JP 49133573A JP 13357374 A JP13357374 A JP 13357374A JP S5826327 B2 JPS5826327 B2 JP S5826327B2
- Authority
- JP
- Japan
- Prior art keywords
- dimethoxy
- methyl
- benzohydroquinone
- yield
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 2,3-dimethoxy-5-methyl 6-substituted-1,4-benzoquinone Chemical class 0.000 claims description 13
- ASUAYTHWZCLXAN-UHFFFAOYSA-N prenol Chemical compound CC(C)=CCO ASUAYTHWZCLXAN-UHFFFAOYSA-N 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 238000000034 method Methods 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000009833 condensation Methods 0.000 description 8
- 230000005494 condensation Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000003463 adsorbent Substances 0.000 description 6
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 6
- 239000004327 boric acid Substances 0.000 description 6
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- RORDEOUGMCQERP-UHFFFAOYSA-N (2Z,6Z,10Z,14Z,18Z,22Z,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-ol Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO RORDEOUGMCQERP-UHFFFAOYSA-N 0.000 description 4
- RORDEOUGMCQERP-CMVHWAPMSA-N (2e,6e,10e,14e,18e,22e,26e,30e,34e)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-ol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO RORDEOUGMCQERP-CMVHWAPMSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229910001923 silver oxide Inorganic materials 0.000 description 3
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000012445 acidic reagent Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 229930002886 farnesol Natural products 0.000 description 2
- 229940043259 farnesol Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- DGQOCLATAPFASR-UHFFFAOYSA-N tetrahydroxy-1,4-benzoquinone Chemical compound OC1=C(O)C(=O)C(O)=C(O)C1=O DGQOCLATAPFASR-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 2
- DSBZYDDWLLIJJS-UHFFFAOYSA-N ubiquinol-0 Chemical compound COC1=C(O)C=C(C)C(O)=C1OC DSBZYDDWLLIJJS-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- TXKJNHBRVLCYFX-UHFFFAOYSA-N (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30E,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyl-tetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-ol Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO TXKJNHBRVLCYFX-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- TUTMVAYTCHJDDP-RYEKIIQNSA-N (6e,10e,14e,18e,22e,26e,30e,34e)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-1,6,10,14,18,22,26,30,34,38-decaen-3-ol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)(O)C=C TUTMVAYTCHJDDP-RYEKIIQNSA-N 0.000 description 1
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- OJISWRZIEWCUBN-QIRCYJPOSA-N (E,E,E)-geranylgeraniol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO OJISWRZIEWCUBN-QIRCYJPOSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- NSPPRYXGGYQMPY-UHFFFAOYSA-N 3-Methylbuten-2-ol-1 Natural products CC(C)C(O)=C NSPPRYXGGYQMPY-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- AFPLNGZPBSKHHQ-UHFFFAOYSA-N Betulaprenol 9 Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO AFPLNGZPBSKHHQ-UHFFFAOYSA-N 0.000 description 1
- BDMCAOBQLHJGBE-UHFFFAOYSA-N C60-polyprenol Natural products CC(=CCCC(=CCCC(=CCCC(=CCCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CCC(=C/CO)C)C)C)C)C)C)C)C)C)C)C)C BDMCAOBQLHJGBE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- TXKJNHBRVLCYFX-RDQGWRCRSA-N all-trans-undecaprenol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO TXKJNHBRVLCYFX-RDQGWRCRSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 229920002672 di-trans,poly-cis-Undecaprenol Polymers 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- CCCXGQLQJHWTLZ-UHFFFAOYSA-N geranyl linalool Natural products CC(=CCCC(=CCCCC(C)(O)CCC=C(C)C)C)C CCCXGQLQJHWTLZ-UHFFFAOYSA-N 0.000 description 1
- XWRJRXQNOHXIOX-UHFFFAOYSA-N geranylgeraniol Natural products CC(C)=CCCC(C)=CCOCC=C(C)CCC=C(C)C XWRJRXQNOHXIOX-UHFFFAOYSA-N 0.000 description 1
- IQDXAJNQKSIPGB-HQSZAHFGSA-N geranyllinalool Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CCC(C)(O)C=C IQDXAJNQKSIPGB-HQSZAHFGSA-N 0.000 description 1
- OJISWRZIEWCUBN-UHFFFAOYSA-N geranylnerol Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO OJISWRZIEWCUBN-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910000464 lead oxide Inorganic materials 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AFPLNGZPBSKHHQ-MEGGAXOGSA-N solanesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO AFPLNGZPBSKHHQ-MEGGAXOGSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
- C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/05—Cyclic compounds having at least one ring containing boron but no carbon in the ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】 本発明は次の化学式(I) 〔式中Rは次式 の基を表わし、SはO−1 水素原子あるいは場合によ 成する事を表わす。[Detailed description of the invention] The present invention relates to the following chemical formula (I) [In the formula, R is the following formula represents a group, S is O-1 hydrogen atom or represents something that is accomplished.
〕1の整数を、A、Bは
りA−Bで結合手を形
で表わされる2・3−ジメトキシ−5−メチル6−置換
−1・4−ベンゾキノンの新規な合成法に関するもので
ある。] This relates to a novel method for synthesizing 2,3-dimethoxy-5-methyl 6-substituted-1,4-benzoquinone in which the bond is represented by the integer 1, A, B, and A-B.
化合物(I)は補酵素Qとして知られ、特にABが結合
手を形成し、Sが9の化合物である2・3−ジメトキシ
−5−メチル−6−ゾカプレニルート4−ベンゾキノン
〔2・3−ジメトキシ5−メチル−6−(3・7・11
・15・19・23・27・31・35・39−デカメ
チルテトラコンタシカエン−2−6・10・14・18
・22 ・26・30・34 ・38−イール)−1・
4−ベンゾキノン〕は補酵素Q+oと称せられるもので
、生体内において電子伝達系に関与すると共にエネルギ
ー産生に重要な役割を果し医学、薬学的見地より多くの
臨床的効果が期待されるものである。Compound (I) is known as coenzyme Q, and is particularly a compound in which AB forms a bond and S is 9, 2,3-dimethoxy-5-methyl-6-zocaprenylroot 4-benzoquinone [2,3-dimethoxy 5-methyl-6-(3.7.11
・15, 19, 23, 27, 31, 35, 39-decamethyltetracontasicaene-2-6, 10, 14, 18
・22 ・26・30・34 ・38-Eel)-1・
4-benzoquinone] is called coenzyme Q+O, and it is involved in the electron transport system in the body and plays an important role in energy production, and is expected to have many clinical effects from a medical and pharmaceutical standpoint. be.
この補酵素Q+oで代表される7連のキノン化合物の合
成法としては、2・3−ジメトキシ6−メチル−1・4
−ベンゾハイドロキノンまたはその1−モノアシレート
と(イン)デカプレノールまたはその反応性誘導体とを
ギ酸、硫酸、塩酸、燐酸、P−トルエンスルホン酸等の
プロトン酸:塩化亜鉛、塩化アルミニウム、三弗化ホウ
素エーテル錯体等のルイス酸あるいはこれらの混合物等
の酸性縮合触媒の存在下に反応させて得られる、縮合生
成物を必要に応じて加水分解操作を施した後酸化して目
的物を得る方法が知られている。The method for synthesizing the seven-chain quinone compound represented by coenzyme Q+o is 2,3-dimethoxy6-methyl-1,4
- benzohydroquinone or its 1-monoacylate and (yne)decaprenol or its reactive derivative in a protic acid such as formic acid, sulfuric acid, hydrochloric acid, phosphoric acid, P-toluenesulfonic acid: zinc chloride, aluminum chloride, boron trifluoride ether complex A method is known in which the desired product is obtained by reacting the condensation product in the presence of an acidic condensation catalyst such as a Lewis acid or a mixture thereof, and then subjecting the condensation product to hydrolysis as necessary and then oxidizing it. There is.
(特公昭39−17513、同39−17514、同4
6−3967参照)。(Special Publications No. 39-17513, No. 39-17514, No. 4
6-3967).
しかしこれらの方法は、縮合工程の収率が良くな(・た
め、目的とするキノン化合物の収率は粗生成物でも高々
30%と非常に低い。However, these methods do not have good yields in the condensation step, so the yield of the desired quinone compound is very low, at most 30% even in the crude product.
さらに使用する酸触媒は何れも腐食性が強く装置上好ま
しくないのみならず、溶出した金属が生成物を汚染し工
業的に実施するに際し、その不利は免れない。Furthermore, the acid catalysts used are not only highly corrosive and undesirable in terms of equipment, but also the eluted metal contaminates the product, which is an unavoidable disadvantage in industrial implementation.
また前記触媒を使用することによって、得られた反応生
成物から目的生成物を分離するにあたって、中和、抽出
等の操作を要し、更に原料に対して多量の触媒を使用し
、その上それらは反応後に廃棄しなげればならない場合
が多(、コスト上並びに公害上の見地から好ましくなく
、工業的に多くの難点を有している。Furthermore, by using the above-mentioned catalyst, operations such as neutralization and extraction are required to separate the desired product from the resulting reaction product, and a large amount of catalyst is used relative to the raw material, and in addition, often have to be discarded after the reaction (which is not desirable from the viewpoint of cost and pollution, and has many industrial difficulties).
この縮合工程の収率向上に関して種々の検討がなされ、
2・3−ジメトキシ−5−メチル−6ハロゲノー1 ・
4−ベンゾハイドロキノン 1・4−ジメトキシメチル
エーテルまたは1・4−ジアセテートと次の化学式(m
)
〔式中Xはハロゲン原子を表わし、Rは前記の意味を表
わす。Various studies have been made to improve the yield of this condensation step,
2,3-dimethoxy-5-methyl-6 halogenol 1 ・
4-benzohydroquinone 1,4-dimethoxymethyl ether or 1,4-diacetate and the following chemical formula (m
) [In the formula, X represents a halogen atom, and R represents the above meaning.
−一−−−一部位は半結合−−−一−−一部位は二重結
合である事を表わす。-1---1 site represents a semi-bond---1--1 site represents a double bond.
〕で表わされるπ−アリル型ニッケル錯体を結合させ、
高収率で対応するベンゾ・・イドロキノン体を得る方法
が開発された。] by bonding a π-allylic nickel complex represented by
A method was developed to obtain the corresponding benzo-hydroquinone in high yield.
(特開昭47−25137、同48−85546)。(Japanese Unexamined Patent Publications No. 47-25137, No. 48-85546).
しかしこれらの方法では縮合収率に関しては、大きな向
上があったが、πアリル型ニッケル錯体(III)を調
製する際に用いるNi(CO)4は、呼吸器系に対し毒
性を示し、またガス状物質であるため、取扱いが煩雑で
工業化が困難である。However, although these methods have greatly improved the condensation yield, the Ni(CO)4 used to prepare the π-allylic nickel complex (III) is toxic to the respiratory system and gaseous. Because it is a spherical substance, handling is complicated and industrialization is difficult.
本発明者等は、化学式(n)で表わされるキノン化合物
を効率よく得る方法の開発を目的としてキノン化合物の
前駆物質である・・イドロキノン化−A★合物を効率よ
く、しかも工業的に得る縮合工程改善の探索に努力し、
本発明の方法に到達した。The present inventors aim to develop a method for efficiently obtaining the quinone compound represented by the chemical formula (n), and to efficiently and industrially obtain the idoquinonation-A compound, which is a precursor of the quinone compound. We strive to improve the condensation process,
The method of the present invention has been arrived at.
本発明の方法は次の一般式(n)
〔式中mは1〜3の整数を、nはO〜2の整数を表わす
。The method of the present invention has the following general formula (n) [where m represents an integer of 1 to 3, and n represents an integer of O to 2].
但しmとnは常にm+n=3の関係を満足させる。However, m and n always satisfy the relationship m+n=3.
〕で表わされる2・3−ジメトキシ−6=メチル−1・
4−ベンゾハイドロキノン 1−ボレートに次の一般式
(m)
〔式中Rは前記の意味を表わす。] 2,3-dimethoxy-6=methyl-1.
4-benzohydroquinone 1-borate has the following general formula (m) [wherein R represents the above-mentioned meaning].
XlあるいはX2は、どちらか一方が水酸基、他方が水
素原子であることを表わす。Xl or X2 represents that one is a hydroxyl group and the other is a hydrogen atom.
〕で表わされる(イソ)プレノールまたはその反応性誘
導体またはその反応性誘導体を反応させ、次の一般式(
IV)
〔式中R,mおよびnは前記の意味を表わす。] (iso)prenol or its reactive derivative or its reactive derivative is reacted to form the following general formula (
IV) [In the formula, R, m and n represent the above meanings.
〕で表わされる2・3−ジメトキシ−5一置換−6−メ
チル−1・4−ベンゾハイドロキノン 1ボレートとな
す工程(以下、■程イと称す)と得られた化合物(IV
)に穏和な酸化剤を作用させて次の一般式(I)
〔式中Rは前記の意味を表わす。] 2,3-dimethoxy-5-monosubstituted-6-methyl-1,4-benzohydroquinone 1borate (hereinafter referred to as ① process) and the obtained compound (IV
) is treated with a mild oxidizing agent to form the following general formula (I) [wherein R represents the above-mentioned meaning].
〕で表わされるキノン化合物;2・3−ジメトキシ5一
置換−6−メチル−1・4−ベンゾキノンとなす工程(
以下、工程口と称す)からなる。2,3-dimethoxy5-monosubstituted-6-methyl-1,4-benzoquinone (
(hereinafter referred to as process port).
工程イにおいてボレー) (n’)に反応させる(イソ
)プレノールまたはその反応性誘導体(III)のモル
比は化合物(II)における2・3−ジメトキシ−6−
メチル−1・4−ベンジノ・イドロキノン部分の組成比
、即ちmに対応する数値である。In step A, the molar ratio of (iso)prenol or its reactive derivative (III) to be reacted with (n') is 2,3-dimethoxy-6- in compound (II).
This is a numerical value corresponding to the composition ratio of the methyl-1,4-benzinohydroquinone moiety, that is, m.
反応は無溶媒または反応に不活性な有機溶媒、例エバベ
ンゼン、トルエン、キシレン、ノルマルヘキサン、シク
ロヘキサン、エチルエーテル、テトラハイドロフラン等
を単独または混合系で用いて行なわれる。The reaction is carried out without a solvent or using an organic solvent inert to the reaction, such as evabenzene, toluene, xylene, n-hexane, cyclohexane, ethyl ether, tetrahydrofuran, etc. alone or in a mixed system.
一般に有機溶媒を使用する事は反応を円滑に行なわせし
める点、反応後の処理が容易である点で有利である。Generally, the use of an organic solvent is advantageous in that the reaction can be carried out smoothly and that post-reaction treatment is easy.
また工程イな行なう方法として、前記した有機溶媒を吸
着溶媒として、化合物(n)または(III)の一方を
例えば硅酸、シリカゲル、白土、カオリン、硅酸マグネ
シウム(フロリジル)、活性炭、パームチット、天然ま
たは合成ゼオライト、アルミナ、シリカアルミナ、シリ
カマグネシア等の通常の化学操作において使用される吸
着剤に吸着させ、これに他方を、必要ならば前記した有
機溶媒で溶解させて、バッチ法またはカラム法操作で吸
着、接触せしめ反応させる。In addition, as a method for carrying out step I, one of compound (n) or (III) can be absorbed using the above-mentioned organic solvent as an adsorption solvent, such as silicic acid, silica gel, clay, kaolin, magnesium silicate (Florisil), activated carbon, palm chit, natural Alternatively, it can be adsorbed onto an adsorbent used in conventional chemical operations such as synthetic zeolite, alumina, silica alumina, silica magnesia, etc., and the other can be dissolved therein, if necessary, with the above-mentioned organic solvent, and then operated in a batch or column method. adsorption, contact and reaction.
反応生成物(IV)は例えばエチルエーテル、イソプロ
ピルエーテル等のエーテル系溶媒、ベンゼン、トルエン
、キシレン等の芳香族炭化水素系溶媒、クロロホルム、
トリクロロエタン等の脂肪族・・ロダン化炭化水素系溶
媒を単独または混合系を用い吸着剤より抽出または溶出
させる事ができる。The reaction product (IV) is, for example, an ether solvent such as ethyl ether or isopropyl ether, an aromatic hydrocarbon solvent such as benzene, toluene, or xylene, chloroform,
Aliphatic or rhodanized hydrocarbon solvents such as trichloroethane can be extracted or eluted from the adsorbent using a single or mixed system.
本発明の出発原料である化合物(III)は2・3ジメ
トキシ−6−メチル−1・4−ベンゾハイドロキノンと
硼酸または硼砂をJ 、 Am、 Chem 。Compound (III), which is a starting material of the present invention, is prepared by combining 2,3 dimethoxy-6-methyl-1,4-benzohydroquinone and boric acid or borax according to J, Am, Chem.
Sec、75.213(1953)の方法に従って反応
させ赤外部吸収 1385CrrL ’ におけるB−
0部位の吸収の伸縮よりその生成を確認した。Sec, 75.213 (1953) and infrared absorption 1385CrrL'.
Its formation was confirmed by the expansion and contraction of absorption at the 0 site.
化合物(n)は水分等に対して非常に不安定なので用時
調整して単離せずに(III)との縮合反応に移行させ
るのが望ましい。Since compound (n) is very unstable against moisture and the like, it is desirable to prepare it before use and proceed to the condensation reaction with (III) without isolation.
本発明における(イソ)プレノールまたはその反応性誘
導体としては例えば3−メチルブテン−2−オール−1
・3−メチルブテン−1−オール−3、ゲラニオール、
リナロール、ネロール、ネロリトール、フィトール、イ
ンフィトール、ゲラニルゲラニオール、ゲラニルリナロ
ール、ケラニルファルネソール、ケラニルネロリドール
、ゲラニルゲラニルファルネソール、ソライ・ソール、
デカプレノール、インデカフレノール、ウンデカプレノ
ール、ドデカプレノールまたはそれらアルコール体から
導かれる低級アルキルエーテル体、エステル体tたfl
ハロゲン化物を挙げる事ができる。Examples of (iso)prenol or its reactive derivative in the present invention include 3-methylbuten-2-ol-1
・3-methylbuten-1-ol-3, geraniol,
Linalool, nerol, nerolitol, phytol, infitol, geranylgeraniol, geranyl linalool, keranyl farnesol, keranyl nerolidol, geranylgeranyl farnesol, Solai Sol,
Decaprenol, indecafrenol, undecaprenol, dodecaprenol or lower alkyl ethers and esters derived from these alcohols
Examples include halides.
工程イで得られた化合物(IV)は単離精製せずに、工
程口に移行させることができる。Compound (IV) obtained in Step A can be transferred to the process entrance without being isolated and purified.
工程口における穏和な酸化剤としては、例えば%公昭3
9 17514に記載されている酸化銀、酸化鉛、塩化
第二鉄等を使用する事ができる。As a mild oxidizing agent at the process entrance, for example, % Kosho 3
Silver oxide, lead oxide, ferric chloride, etc. described in No. 9 17514 can be used.
本発明の方法は前述した従来の方法に比較して次の点で
大きな改善があった。The method of the present invention has significant improvements over the conventional method described above in the following points.
(1)収率の向上
本発明の方法では工程イの縮合効率がよいため最終目的
物であるキノン体(I)が高収率で得られる。(1) Improvement in Yield In the method of the present invention, the condensation efficiency in step (a) is high, so that the final target product, quinone compound (I), can be obtained in high yield.
例えば補酵素Q1oでは吸着剤を使用しない場合22%
またはそれ以上で、吸着剤を使用した場合は45%また
はそれ以上で純品が得られた。For example, for coenzyme Q1o, it is 22% when no adsorbent is used.
or more, and when using an adsorbent, 45% or more pure product was obtained.
(il)工程数の減少
化合物(IV ) It増化の工程を要すに直接酸化を
うけて化合物(I)に変換されるので、鹸化の工程が不
要である。(il) Reduction in the number of steps Compound (IV) Since the It-increasing step is directly oxidized and converted to Compound (I), the saponification step is not necessary.
(lii) 装置等の腐蝕防止、公害防止の効果従来
2・3−ジメトキシ−5−メチル−1・4−ベンゾハイ
ドロキノンまたはその誘導体と(イソ)プレノールまた
はその反応性誘導体との縮合に際しては塩化亜鉛、3弗
化硼素工−テル錯体等の酸性試薬を縮合触媒として用い
ているが、これら酸性試薬は反応装置に対する腐蝕性が
強いので反応装置の材質は耐蝕性のものを使用しなげれ
ばならず、また金属・・ライド等を使用した場合、溶出
する金属イオンが公害の原因となるが、本発明の方法で
はこれら酸性縮合触媒を使用しないためこれらの懸念が
ない。(lii) Effect of preventing corrosion and pollution of equipment, etc. Conventionally, when condensing 2,3-dimethoxy-5-methyl-1,4-benzohydroquinone or its derivative with (iso)prenol or its reactive derivative, zinc chloride was Acidic reagents such as trifluoroboronate complex are used as condensation catalysts, but these acidic reagents are highly corrosive to the reaction equipment, so corrosion-resistant materials must be used for the reaction equipment. Furthermore, when metal rides are used, the eluted metal ions cause pollution, but the method of the present invention eliminates these concerns because these acidic condensation catalysts are not used.
以上より本発明の方法は従来法に比較して、より工業的
に優れた方法であるといえる。From the above, it can be said that the method of the present invention is industrially superior to the conventional method.
次に実施例により本発明を説明する。Next, the present invention will be explained with reference to examples.
実施例 1
2・3−ジメトキシ−5−メチル−6−デカフレニル−
ベンゾキノン−1・4の製法
2・3−ジメトキシ−5−メチル−ベンツハイドロキノ
ン−1・4(11fりと硼酸36Zをベンゼン50Tr
Llに加え加熱する。Example 1 2,3-dimethoxy-5-methyl-6-decafrenyl-
Preparation method of benzoquinone-1,4 2,3-dimethoxy-5-methyl-benzhydroquinone-1,4 (11f) and boric acid 36Z are mixed with benzene 50Tr
Add to Ll and heat.
共沸混合物を除去した後、ベンセンを留去する。After removing the azeotrope, the benzene is distilled off.
残留物にトルエン10m1を加え、50〜55℃で加熱
、攪拌下にイソデカプレノール(純度90%)141を
加え更に同一条件で5時間攪拌を継続する。10 ml of toluene is added to the residue, heated at 50 to 55°C, and while stirring, isodecaprenol (purity 90%) 141 is added, and stirring is continued for 5 hours under the same conditions.
反応終了後、反応混合物をエチルエーテル200rnl
で抽出し、1−フル抽出液を水洗、アルカリ水洗、つい
で芒硝乾燥する。After the reaction is complete, the reaction mixture is diluted with 200rnl of ethyl ether.
The 1-full extract was washed with water, washed with alkaline water, and then dried with mirabilite.
このエーテル抽出液に酸化銀6グを加え、攪拌下、室温
で一夜放置する。Add 6 g of silver oxide to this ether extract, and let stand overnight at room temperature while stirring.
反応混合物をr過し、p液より溶媒を留去する。The reaction mixture is filtered and the solvent is distilled off from the p liquid.
油状残渣15.9Pを得る。An oily residue of 15.9 P is obtained.
これを5%エチルエーテル含有n−ヘキサンを溶出溶媒
としてシリカゲルクロマトにより精製する。This is purified by silica gel chromatography using n-hexane containing 5% ethyl ether as an eluent.
溶媒を留去して橙黄色油状物質5.42を得る。Evaporation of the solvent yields an orange-yellow oil 5.42.
これをアセトンより結晶化し、融点49℃を示す橙色結
晶を得る。This is crystallized from acetone to obtain orange crystals with a melting point of 49°C.
収量3.9P(収率22.6%)
紫外部吸収スペクトル測定値、赤外部吸収スペクトル測
定値、核磁気共鳴スペクトル測定値およびマススペクト
ル測定値により標品と同定された。Yield: 3.9P (yield: 22.6%) It was identified as the standard product based on ultraviolet absorption spectrum measurements, infrared absorption spectrum measurements, nuclear magnetic resonance spectrum measurements, and mass spectrum measurements.
実施例 2
2・3−ジメトキシ−5−メチル−6−デカプレニルー
ペンゾキノンート4の製法
2・3−ジメトキシ−5−メチルーベンソハイドロキノ
ンート4(11グ)と硼酸3.6′?をトルエン中で還
流し、共沸混合物を除去した後、トルエンを留去する。Example 2 Preparation of 2,3-dimethoxy-5-methyl-6-decaprenylpenzoquinone 4 2,3-dimethoxy-5-methyl-benzohydroquinone 4 (11 g) and boric acid 3.6' ? After refluxing in toluene and removing the azeotrope, the toluene is distilled off.
残留物にベンゼン20m1、ヘキサン30m1、シリカ
アルミナN−633H(日揮化学製品)172を加える
。20 ml of benzene, 30 ml of hexane, and 172 ml of silica alumina N-633H (JGC Chemicals) are added to the residue.
これを30℃で加熱攪拌下にデカプレノール(純度94
%)142をn−へキサン10m1に溶解した溶液を3
0分間を要して滴下して加え、更に同温度で40分間攪
拌を継続する。This was heated and stirred at 30°C and decaprenol (purity 94
%) 142 dissolved in 10 ml of n-hexane.
The mixture was added dropwise over 0 minutes, and stirring was continued for 40 minutes at the same temperature.
反応終了後、吸着剤を戸別し、得られたp液を濃縮し、
得られた残渣をエチルエーテル300m1で抽出し、エ
ーテル抽出液を水洗、アルカリ水洗ついで芒硝乾燥する
。After the reaction is completed, the adsorbent is removed from door to door, the resulting p liquid is concentrated,
The resulting residue was extracted with 300 ml of ethyl ether, and the ether extract was washed with water, washed with alkaline water, and dried with sodium sulfate.
このエーテル抽出液に酸化銀61を加え、攪拌下、室温
で一夜放置する。Silver oxide 61 was added to this ether extract, and the mixture was allowed to stand overnight at room temperature while stirring.
反応混合物をp過しp液より溶媒を留去して油状残i1
6..llを得る。The reaction mixture was filtered and the solvent was distilled off from the p solution to form an oily residue i1.
6. .. get ll.
これを5%エチルエーテル含有n−ヘキサンを溶出溶媒
としてシリカゲルクロマトにより精製する。This is purified by silica gel chromatography using n-hexane containing 5% ethyl ether as an eluent.
溶媒を留去して橙黄色油状物質1071を得る。The solvent is distilled off to obtain orange-yellow oil 1071.
このものは薄層および逆層クロマトグラフィーにてモノ
スポットを与えた。This gave monospots in thin layer and reverse layer chromatography.
上記油状物質をアセトンより結晶化し、融点49°Cを
示す橙黄色結晶を得る。The above oily substance is crystallized from acetone to obtain orange-yellow crystals with a melting point of 49°C.
収量8.51(収率49.2%) 実施例1と同様の各種測定を行ない標品と同定した。Yield 8.51 (yield 49.2%) Various measurements similar to those in Example 1 were performed and the product was identified as a standard product.
実施例 3
2 ・3−ジメトキシ−5−メチル−6−ゾカプレニル
ーペンゾキノンー1・4の製法
2・3−ジメトキシ−5−メチル−ベンゾハイドロキノ
ン−1・4. (11P )、硼酸3.61、デカプレ
ノール(純度94%)142を実施例2に従って反応処
理する。Example 3 2. Preparation of 3-dimethoxy-5-methyl-6-zocaprenylpenzoquinone-1.4 2.3-dimethoxy-5-methyl-benzohydroquinone-1.4. (11P), boric acid 3.61, and decaprenol (94% purity) 142 were reacted according to Example 2.
但し吸着剤としてワコーゲルC−200(和光紬薬製品
)21’を使用し縮合反応温度は70℃とした。However, Wakogel C-200 (Wako Tsumugi Products) 21' was used as an adsorbent, and the condensation reaction temperature was 70°C.
融点49℃の橙黄色結晶を得た。Orange-yellow crystals with a melting point of 49°C were obtained.
収量7.72(収率446%) 実施例1と同様の測定を行ない標品と同定した。Yield 7.72 (yield 446%) The same measurements as in Example 1 were carried out and it was identified as a standard product.
実施例 4
2・3−ジメトキシ−5−メチル−6−ノナフレニル−
ベンゾキノン−1・4の製法
2・3−ジメトキシ−5−メチル−ベンゾハイドロキノ
ン−1・4(1[’)、ホウ砂362、ソラネソール1
2.61を実施例1に従って反応処理する。Example 4 2,3-dimethoxy-5-methyl-6-nonafrenyl-
Production method of benzoquinone-1, 4 2, 3-dimethoxy-5-methyl-benzohydroquinone-1, 4 (1['), borax 362, solanesol 1
2.61 is reacted according to Example 1.
融点45℃を示す橙色結晶を得る。Orange crystals are obtained with a melting point of 45°C.
収量4.1′?(収率25.8%) 実施例1と同様の測定を行ない標品と同定した。Yield 4.1'? (Yield 25.8%) The same measurements as in Example 1 were carried out and it was identified as a standard product.
実施例 5
2・3−ジメトキシ−5−メチル−6−フィチル−ベン
ゾキノン−1・4の製法
2・3−ジメトキシ−5−メチル−ベンゾハイドロキノ
ン−1・4(18グ)、ホウ酸5.9グ、インフィトー
ル(純度90%)111を実施例2に従って反応処理す
る。Example 5 Preparation of 2,3-dimethoxy-5-methyl-6-phytyl-benzoquinone-1,4 2,3-dimethoxy-5-methyl-benzohydroquinone-1,4 (18 g), boric acid 5.9 Infitol (90% purity) 111 is reacted according to Example 2.
赤色油状物質として目的物を得た。The desired product was obtained as a red oily substance.
収量133P(収率846%) 実施例1と同様の各種測定を行ない標品と同定した。Yield 133P (yield 846%) Various measurements similar to those in Example 1 were performed and the product was identified as a standard product.
実施例 6
2・3−ジメトキシ−5−メチル−6−7レニルーペン
ゾキノンー1・4の製法
2・3−ジメトキシ−5−メチルーベンゾハイドロキノ
ン−1・4(18グ)、ホウ酸5.6P13−メチル−
ブテン−1−オール−361を実施例2に従って反応処
理する。Example 6 Preparation of 2,3-dimethoxy-5-methyl-6-7renylpenzoquinone-1,4 2,3-dimethoxy-5-methyl-benzohydroquinone-1,4 (18 g), boric acid 5.6P13-methyl-
Buten-1-ol-361 is reacted according to Example 2.
目的物を濃赤色油状物質として得る。The desired product is obtained as a dark red oil.
収量121(収率58.0%) 実施例1と同様の各種測定を行ない標品と同定した。Yield 121 (yield 58.0%) Various measurements similar to those in Example 1 were performed and the product was identified as a standard product.
Claims (1)
。 但しmとnは常にm+n=3の関係を満足させる。 〕で表わされる2・3−ジメトキシ−6−メチルート4
−ベンゾハイドロキノン1−ボレートに次の一般式 〔式中X1あるいはX2は、どちらか一方が水酸基、他
方が水素原子であることを表わす。 Rは次式 の基を表わし、SはO〜11の整数を、A、Bは水素原
子あるL・は場合によりl−Bで結合手を形成する事を
表わす。 〕で表わされるプレノールまたはイソフレノールを反応
させ、得られた次の一般式 〔式中R,mおよびnは前記の意味を表わす。 〕で表わされる2・3−ジメトキシ−5一置換−6−メ
チル−1・4−ベンゾハイドロキノン 1−ボレートに
穏和な酸化剤を反応させる事を特徴とする、次式 〔式中Rは前記の意味を表わす。 〕で表わされる2・3−ジメトキシ−5−メチル6−置
換−1・4−ベンゾキノンの製造方法。[Scope of Claims] First-order general formula [where m represents an integer of 1 to 3 and n represents an integer of O to 2]. However, m and n always satisfy the relationship m+n=3. ] 2,3-dimethoxy-6-methylto 4
-Benzohydroquinone 1-borate has the following general formula [wherein X1 or X2 represents that one is a hydroxyl group and the other is a hydrogen atom. R represents a group of the following formula, S represents an integer from O to 11, A and B represent hydrogen atoms, and L. represents forming a bond with 1-B in some cases. ] Prenol or isofrenol represented by the following general formula [wherein R, m and n represent the above-mentioned meanings] was obtained. 2,3-dimethoxy-5-monosubstituted-6-methyl-1,4-benzohydroquinone 1-borate represented by the following formula [wherein R is express meaning. ] A method for producing 2,3-dimethoxy-5-methyl 6-substituted-1,4-benzoquinone.
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49133573A JPS5826327B2 (en) | 1974-11-22 | 1974-11-22 | Hokosokyuuruino Goseihou |
| CH1497975A CH613682A5 (en) | 1974-11-22 | 1975-11-19 | Process for the preparation of substituted dimethoxymethylbenzoquinones |
| DE2552365A DE2552365C2 (en) | 1974-11-22 | 1975-11-21 | Process for the preparation of 2,3-dimethoxy-5-methyl-1,4-benzoquinones substituted in the 6-position |
| GB47905/75A GB1529326A (en) | 1974-11-22 | 1975-11-21 | Boron esters and their use in a process for synthesis of coenzymes q |
| SE7513127A SE431325B (en) | 1974-11-22 | 1975-11-21 | PROCEDURE FOR PREPARING 6-SUBSTITUTED 2,3-DIMETOXY-5-METHYL-1,4-BENZOQINONS |
| ES442888A ES442888A1 (en) | 1974-11-22 | 1975-11-21 | A procedure for the synthesis of substitute 2,3-dimetoxy-5-methyl-1,4-benzoquinones-6. (Machine-translation by Google Translate, not legally binding) |
| NLAANVRAGE7513705,A NL184778C (en) | 1974-11-22 | 1975-11-24 | PROCESS FOR PREPARING 6-ALKENYL-2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE AND METHOD FOR PREPARING ESTERS OF 6-ALKENYL-2,3-DIMETHOXY-5-METHYL-HYDROQUINONE |
| FR7535860A FR2291980A1 (en) | 1974-11-22 | 1975-11-24 | Q COENZYME SYNTHESIS PROCESS |
| US05/725,427 US4057568A (en) | 1974-11-22 | 1976-09-22 | Process for synthesis of boric acid ester |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49133573A JPS5826327B2 (en) | 1974-11-22 | 1974-11-22 | Hokosokyuuruino Goseihou |
| US05/725,427 US4057568A (en) | 1974-11-22 | 1976-09-22 | Process for synthesis of boric acid ester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5163139A JPS5163139A (en) | 1976-06-01 |
| JPS5826327B2 true JPS5826327B2 (en) | 1983-06-02 |
Family
ID=26467897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49133573A Expired JPS5826327B2 (en) | 1974-11-22 | 1974-11-22 | Hokosokyuuruino Goseihou |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5826327B2 (en) |
| CH (1) | CH613682A5 (en) |
| DE (1) | DE2552365C2 (en) |
| FR (1) | FR2291980A1 (en) |
| GB (1) | GB1529326A (en) |
| NL (1) | NL184778C (en) |
| SE (1) | SE431325B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0541417U (en) * | 1991-03-20 | 1993-06-08 | ハクバ写真産業株式会社 | Handle of the trunk case |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6058209B2 (en) | 1978-12-01 | 1985-12-19 | エーザイ株式会社 | β,γ-dihydropolyprenyl alcohol and antihypertensive agents consisting of it |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH376898A (en) * | 1958-08-07 | 1964-04-30 | Hoffmann La Roche | Process for the preparation of 2,3-dimethoxy-5-methyl-benzohydroquinones- (1,4) or benzoquinones- (1,4) substituted in the 6-position |
-
1974
- 1974-11-22 JP JP49133573A patent/JPS5826327B2/en not_active Expired
-
1975
- 1975-11-19 CH CH1497975A patent/CH613682A5/en not_active IP Right Cessation
- 1975-11-21 SE SE7513127A patent/SE431325B/en not_active IP Right Cessation
- 1975-11-21 DE DE2552365A patent/DE2552365C2/en not_active Expired
- 1975-11-21 GB GB47905/75A patent/GB1529326A/en not_active Expired
- 1975-11-24 NL NLAANVRAGE7513705,A patent/NL184778C/en not_active IP Right Cessation
- 1975-11-24 FR FR7535860A patent/FR2291980A1/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0541417U (en) * | 1991-03-20 | 1993-06-08 | ハクバ写真産業株式会社 | Handle of the trunk case |
Also Published As
| Publication number | Publication date |
|---|---|
| CH613682A5 (en) | 1979-10-15 |
| SE7513127L (en) | 1976-05-24 |
| NL7513705A (en) | 1976-05-25 |
| FR2291980A1 (en) | 1976-06-18 |
| DE2552365A1 (en) | 1976-05-26 |
| NL184778C (en) | 1989-11-01 |
| FR2291980B1 (en) | 1978-05-12 |
| JPS5163139A (en) | 1976-06-01 |
| DE2552365C2 (en) | 1985-10-24 |
| GB1529326A (en) | 1978-10-18 |
| SE431325B (en) | 1984-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4163864A (en) | Process for preparing 2-methyl-3-prenyl-4,5,6-trimethoxyphenol | |
| JPS62252740A (en) | Intermediate for manufacturing insecticide | |
| JPS5826327B2 (en) | Hokosokyuuruino Goseihou | |
| US4039573A (en) | Process for preparation of 1,4-benzohydroquinone derivatives | |
| US4089873A (en) | Preparation of menaquinones | |
| Caine et al. | Synthesis and photochemical rearrangement of (1 (R), 7a (S))-1-(tert-butyldiphenylsiloxy)-7a-methyl-5 (7aH)-indanone | |
| CN117285411B (en) | A preparation method of 2'-bromo-o-fluoroacetophenone | |
| US3998858A (en) | Process for synthesis of coenzymes q | |
| JPS604164B2 (en) | Method for synthesizing coenzyme Q compounds | |
| EP0563825B1 (en) | Process for producing vitamin A acid | |
| JPS5925772B2 (en) | Synthesis method of supplementary element Q class compounds | |
| JPS601292B2 (en) | Synthesis method of dihydrocoenzyme Q compounds | |
| US4057568A (en) | Process for synthesis of boric acid ester | |
| English Jr et al. | The Synthesis and Rearrangement of Some Decahydro-and Tetrahydronaphthalenediols | |
| US4496771A (en) | Process for preparing the compound 1-decyloxy-4-[(7-oxa-4-octynyl)-oxy]-benzene | |
| US20080200733A1 (en) | Processes For The Preparation Of Purified Solanesol, Solanesyl Bromide & Solanesyl Acetone | |
| EP1910263A2 (en) | Novel intermediates useful for the preparation of coenzymes, process for the preparation of novel intermediates and an improved process for the preparation of coenzymes | |
| JP3918120B2 (en) | Method for producing 3,7-dimethyl-2,6-octadiene-4-olide | |
| JPS6139933B2 (en) | ||
| US4234746A (en) | Metallo-substituted naphthalene | |
| US4159993A (en) | 3-Metallo substituted naphthalenes | |
| RU2551655C1 (en) | Method for producing (3-hydroxypropyl)naphthols | |
| EP0138575B1 (en) | Process for the preparation of 2,3-cis-1,2,3,4-tetrahydro-5-[(2-hydroxy-3-tert.butylamino)propoxy]-2,3-naphthalenediol and new intermediate for use therein | |
| Collins et al. | A Difficulty Encountered in the Use of Methyltriphenylphosphonium Iodide in the Wittig Reaction | |
| JPS6236018B2 (en) |